Skye Bioscience, Inc. (SKYE) NASDAQ
0.82
+0.0923(+12.77%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
0.82
+0.0923(+12.77%)
Currency In USD
| Market Cap | 29.74M |
| Enterprise Value | 24.13M |
| P/E Ratio | -0.58 |
| PEG Ratio | 0.06 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 1.61 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | 0 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -1.98 |
| Return On Equity | -1.44 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | -723,352 |
| EBITDA | -57.44M |
| Net Income | -55.92M |
| Diluted EPS | -1.41 |
| Total Cash | 25.74M |
| Total Cash/Share | 0.65 |
| Total Debt | 273,646 |
| Total Debt/Equity | 0.01 |
| Current Ratio | 3.3 |
| Book Value Per Share | 0.5 |
| 52-Week Change | -37.77 |
| 52-Week High | 5.75 |
| 52-Week Low | 0.57 |
| Moving Average 50 Days | 0.73 |
| Moving Average 200 Days | 2.02 |
| Average Volume | 553,385 |
| Shares Outstanding | 33.38M |
| % Held by Institutions | 40.67 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:250 |
| Last Split Date | September 08, 2023 |